Ge Health Care Technologies Inc. GEHC
We take great care to ensure that the data presented and summarized in this overview for GE HealthCare Technologies Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in GEHC
Top Purchases
Top Sells
About GEHC
Insider Transactions at GEHC
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 01
2024
|
James Saccaro Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,740
-2.76%
|
$146,160
$84.82 P/Share
|
|
Sep 01
2024
|
Roland Rott CEO, Imaging |
SELL
Payment of exercise price or tax liability
|
Direct |
685
-2.74%
|
$57,540
$84.82 P/Share
|
|
Sep 01
2024
|
Philip Rackliffe CEO, Ultrasound & IGT |
SELL
Payment of exercise price or tax liability
|
Direct |
1,553
-5.17%
|
$130,452
$84.82 P/Share
|
|
Sep 01
2024
|
Peter J Arduini President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,859
-5.18%
|
$492,156
$84.82 P/Share
|
|
Sep 01
2024
|
Frank R Jimenez GC & Corporate Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
1,699
-2.24%
|
$142,716
$84.82 P/Share
|
|
Sep 01
2024
|
Taha Kass Hout Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,598
-2.37%
|
$134,232
$84.82 P/Share
|
|
Sep 01
2024
|
Kenneth R. Stacherski Ch. Supply Chain & Serv. Ofc. |
SELL
Payment of exercise price or tax liability
|
Direct |
458
-1.19%
|
$38,472
$84.82 P/Share
|
|
Aug 17
2024
|
H Lawrence Culp Jr Director |
SELL
Payment of exercise price or tax liability
|
Direct |
291,053
-46.64%
|
$24,448,452
$84.8 P/Share
|
|
Aug 15
2024
|
Philip Rackliffe CEO, Ultrasound & IGT |
BUY
Grant, award, or other acquisition
|
Direct |
2,051
+11.91%
|
-
|
|
Aug 15
2024
|
Roland Rott CEO, Imaging |
BUY
Grant, award, or other acquisition
|
Direct |
2,784
+10.03%
|
-
|
|
Aug 15
2024
|
Adam Y Holton Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,895
+44.86%
|
-
|
|
Aug 14
2024
|
Kenneth R. Stacherski Ch. Supply Chain & Serv. Ofc. |
SELL
Open market or private sale
|
Direct |
19,008
-33.03%
|
$1,577,664
$83.22 P/Share
|
|
Aug 07
2024
|
Thomas J. Westrick CEO, Patient Care Solutions |
SELL
Open market or private sale
|
Direct |
2,750
-13.57%
|
$220,000
$80.78 P/Share
|
|
Aug 03
2024
|
Kevin Michael O'Neill CEO, PDx |
SELL
Payment of exercise price or tax liability
|
Direct |
1,533
-6.38%
|
$127,239
$83.44 P/Share
|
|
Aug 03
2024
|
Roland Rott CEO, Imaging |
SELL
Payment of exercise price or tax liability
|
Direct |
1,630
-6.84%
|
$135,290
$83.44 P/Share
|
|
Jun 01
2024
|
James Saccaro Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,998
-12.51%
|
$701,844
$78.0 P/Share
|
|
May 28
2024
|
Taha Kass Hout Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
3,300
-4.67%
|
$257,400
$78.7 P/Share
|
|
May 21
2024
|
Rodney F Hochman Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,965
+20.02%
|
-
|
|
May 21
2024
|
Lloyd Howell Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,440
+28.83%
|
-
|
|
May 21
2024
|
Risa J Lavizzo Mourey Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,440
+25.67%
|
-
|
Last 12 Months Summary
Buy / Acquisition
223K
Shares
From
23
Insiders
| Grant, award, or other acquisition | 135K shares |
|---|---|
| Open market or private purchase | 1.32K shares |
| Exercise of conversion of derivative security | 87.2K shares |
Sell / Disposition
29.5M
Shares
From
18
Insiders
| Payment of exercise price or tax liability | 431K shares |
|---|---|
| Open market or private sale | 112K shares |
| Other acquisition or disposition | 29M shares |